To study the effects of a possible treatment for glioblastomas involving the inhibition of IGF1R signaling, we repeated the injection of immunodeficient mice with U87WT and U87Mut clones, and when a tumor developed, we treated the mice with OSI906. The gene discussed is IGF1R; the disease is glioblastoma.